Rayan Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.66 M
- Company Age 37 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.65 M
- Revenue Growth %
- Profit Growth -120.00%
- Ebitda -120.00%
- Net Worth -0.96%
- Total Assets %
About Rayan Pharma
Rayan Pharma Limited (RPL) is a Public Limited Indian Non-Government Company incorporated in India on 30 March 1987 and has a history of 37 years and ten months. Its registered office is in Godavari, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.66 M.
The company currently has active open charges totaling ₹7.65 M.
Venkata Grandi, Ranganayakamurthy Pedamallu, and Subhadra Pedamallu serve as directors at the Company.
Company Details
-
Location
Godavari, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200AP1987PLC007320
-
Company No.
007320
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 1987
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Rayan Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranganayakamurthy Pedamallu
|
Managing Director | 10-Feb-2006 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Venkata Grandi
|
Director | 13-Mar-2006 | Current |
|
Subhadra Pedamallu
|
Director | 10-Feb-2006 | Current |
Financial Performance of Rayan Pharma.
Rayan Pharma Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 120% decrease in profit. The company's net worth dipped by a decrease of 0.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rayan Pharma?
In 2022, Rayan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.65 M
₹0
Charges Breakdown by Lending Institutions
- Andhra Pradesh State Financial Corporation : 0.59 Cr
- State Bank Of India : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 1999 | Andhra Pradesh State Financial Corporation | ₹2.00 M | Open |
| 06 Jun 1997 | Andhra Pradesh State Financial Corporation | ₹3.20 M | Open |
| 14 Nov 1992 | Andhra Pradesh State Financial Corporation | ₹0.73 M | Open |
| 03 Aug 1992 | State Bank Of India | ₹0.12 M | Open |
| 21 May 1991 | State Bank Of India | ₹0.40 M | Open |
How Many Employees Work at Rayan Pharma?
Unlock and access historical data on people associated with Rayan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rayan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.